Amymagnesium de citrateris has executed a Memorandum of Understanding for a collaboration with a partnerzinc sulphate and zinc gluconate in food ingredients and nutraceuticals. ###Upon rpure encapsulations magnesiumcitrat 180equired approval and execution of definitive agreements with this new partner, Amyris expects to receive:###– cash representing a short-term collaboration investment of US$10 million, ###– an equity investment of upmagnesium citrat to US$20 million at US$1.40 per share, ###– US$100 million in annual revenue starting in 2017 connected to the production and cost improvement of fermentation molecules,calcium citrate and zinc and ###– participation in the partner’s industrial fermentation facilities in Asia. ###This relationship follows a series of significant partnerships the company has announced in recent months, including a partnership with another company in the nutraceuticals space that was announced on September 30, 2016. ###Both parties have agreed to keep the partner’s name confidential for now.###Amyris applies its bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products.